108 related articles for article (PubMed ID: 35837201)
1. Association of social determinants of health with late diagnosis and survival of patients with pancreatic cancer.
Fabregas JC; Riley KE; Brant JM; George TJ; Orav EJ; Lam MB
J Gastrointest Oncol; 2022 Jun; 13(3):1204-1214. PubMed ID: 35837201
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic Factors Associated With a Late-Stage Pancreatic Cancer Diagnosis: An Analysis of the National Cancer Database.
Gallegos JM; Taylor A; Vardell V; Silberstein PT
Cureus; 2023 Mar; 15(3):e35857. PubMed ID: 37033563
[TBL] [Abstract][Full Text] [Related]
3. Disparities in outcomes and access to therapy options in hepatocellular carcinoma.
Beltrán Ponce S; Gokun Y; Douglass F; Dawson L; Miller E; Thomas CR; Pitter K; Conteh L; Diaz DA
J Natl Cancer Inst; 2024 Feb; 116(2):264-274. PubMed ID: 37831897
[TBL] [Abstract][Full Text] [Related]
4. Impact of Sociodemographic Disparities and Insurance Status on Survival of Patients with Early-Onset Colorectal Cancer.
Salem ME; Puccini A; Trufan SJ; Sha W; Kadakia KC; Hartley ML; Musselwhite LW; Symanowski JT; Hwang JJ; Raghavan D
Oncologist; 2021 Oct; 26(10):e1730-e1741. PubMed ID: 34288237
[TBL] [Abstract][Full Text] [Related]
5. The association of health insurance with the survival of cancer patients with brain metastases at diagnosis.
Kolomaya A; Amin S; Lin C
Tech Innov Patient Support Radiat Oncol; 2021 Dec; 20():46-53. PubMed ID: 34926840
[TBL] [Abstract][Full Text] [Related]
6. Differences in outcome for patients with cholangiocarcinoma: Racial/ethnic disparity or socioeconomic factors?
Lee RM; Liu Y; Gamboa AC; Staley CA; Kooby D; Russell MC; Cardona K; Maithel SK
Surg Oncol; 2020 Sep; 34():126-133. PubMed ID: 32891317
[TBL] [Abstract][Full Text] [Related]
7. Racial and Socioeconomic Disparities in Mantle Cell Lymphoma.
Shah NN; Xi Y; Liu Y; Koff JL; Flowers CR; Behera M; Cohen JB
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e312-e320. PubMed ID: 31029647
[TBL] [Abstract][Full Text] [Related]
8. Association of Insurance and Community-Level Socioeconomic Status With Treatment and Outcome of Squamous Cell Carcinoma of the Pharynx.
Shin JY; Yoon JK; Shin AK; Blumenfeld P; Mai M; Diaz AZ
JAMA Otolaryngol Head Neck Surg; 2017 Sep; 143(9):899-907. PubMed ID: 28662244
[TBL] [Abstract][Full Text] [Related]
9. Access Denied: Inequities in Clinical Trial Enrollment for Pancreatic Cancer.
Eskander MF; Gil L; Beal EW; Li Y; Hamad A; Oppong B; Obeng-Gyasi S; Tsung A
Ann Surg Oncol; 2022 Feb; 29(2):1271-1277. PubMed ID: 34655352
[TBL] [Abstract][Full Text] [Related]
10. Significance of Social Determinants of Health in Tumor Presentation, Hospital Readmission, and Overall Survival in Ocular Oncology.
Choudhry HS; Patel AM; Nguyen HN; Kaleem MA; Handa JT
Am J Ophthalmol; 2024 Apr; 260():21-29. PubMed ID: 37956780
[TBL] [Abstract][Full Text] [Related]
11. Impact of Medicaid Expansion Status and Race on Metastatic Disease at Diagnosis in Patients with Melanoma.
Fabregas JC; Carter BT; Lutzky J; Robinson WR; Brant JM
J Racial Ethn Health Disparities; 2022 Dec; 9(6):2291-2299. PubMed ID: 34648145
[TBL] [Abstract][Full Text] [Related]
12. Social determinants of health associated with poor outcome for rural patients following resected pancreatic cancer.
Chu QD; Hsieh MC; Gibbs JF; Wu XC
J Gastrointest Oncol; 2021 Dec; 12(6):2567-2578. PubMed ID: 35070388
[TBL] [Abstract][Full Text] [Related]
13. The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis.
Amin S; Baine M; Meza J; Lin C
BMC Cancer; 2020 Jun; 20(1):538. PubMed ID: 32517661
[TBL] [Abstract][Full Text] [Related]
14. Association of Type of Treatment Facility With Overall Survival After a Diagnosis of Head and Neck Cancer.
Carey RM; Fathy R; Shah RR; Rajasekaran K; Cannady SB; Newman JG; Ibrahim SA; Brant JA
JAMA Netw Open; 2020 Jan; 3(1):e1919697. PubMed ID: 31977060
[TBL] [Abstract][Full Text] [Related]
15. Impact of immunotherapy use in patients with stage IV pancreatic carcinoma.
Guddati AK; Komiya T; Patel SJ; Sharma N; Powell E
J Gastrointest Oncol; 2020 Aug; 11(4):654-662. PubMed ID: 32953149
[TBL] [Abstract][Full Text] [Related]
16. The impact of stereotactic body radiation therapy on the overall survival of patients diagnosed with early-stage non-small cell lung cancer.
Amin SA; Alam M; Baine MJ; Meza JL; Bennion NR; Zhang C; Rahman I; Lin C
Radiother Oncol; 2021 Feb; 155():254-260. PubMed ID: 33317997
[TBL] [Abstract][Full Text] [Related]
17. Odds of Stage IV Bone Cancer Diagnosis Based on Socioeconomic and Geographical Factors: A National Cancer Database (NCDB) Review.
McMahon KM; Eaton V; Srikanth KK; Tupper C; Merwin M; Morris M; Silberstein PT
Cureus; 2023 Feb; 15(2):e34819. PubMed ID: 36919067
[TBL] [Abstract][Full Text] [Related]
18. The Patient Protection and Affordable Care Act dependent coverage expansion: Disparities in impact among young adult oncology patients.
Alvarez EM; Keegan TH; Johnston EE; Haile R; Sanders L; Wise PH; Saynina O; Chamberlain LJ
Cancer; 2018 Jan; 124(1):110-117. PubMed ID: 28940423
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Payer Status on Survival of Patients With Prostate Cancer.
Suh W; Master S; Liu L; Mills G; Shi R
Cureus; 2021 Feb; 13(2):e13329. PubMed ID: 33738172
[TBL] [Abstract][Full Text] [Related]
20. Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy.
Kim S; DiPeri TP; Guan M; Placencio-Hickok VR; Kim H; Liu JY; Hendifar A; Klempner SJ; Nipp R; Gangi A; Burch M; Waters K; Cho M; Chao J; Atkins K; Kamrava M; Tuli R; Gong J
World J Gastrointest Surg; 2020 Sep; 12(9):377-389. PubMed ID: 33024512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]